Herpes simplex virus type 1 replication machinery

The herpes simplex virus type 1 replication machinery is a multi-component enzyme complex composed of both viral and host proteins that enables the replication of the HSV-1 double-stranded DNA genome inside host cell nuclei. The core viral replication machinery consists of seven essential proteins: origin binding protein UL9, single-stranded DNA binding protein ICP8, helicase–primase complex (UL5 [helicase], UL8 [accessory], UL52 [primase]), DNA polymerase (UL30), and processivity factor (UL42)[2][3][4]. This machinery coordinates the unwinding of viral DNA, primer synthesis, replication, and the protection and packaging of new genomes. HSV-1 hijacks the host's transcriptional and chromatin-modifying proteins during replication, forming specialized replication compartments within the nucleus[1][4]. The replication machinery is a proven therapeutic target for antiviral drugs, most notably nucleoside analogs like acyclovir that inhibit the viral DNA polymerase, and more recently, small molecules inhibiting the helicase–primase complex[2][3]. The "HSV-1 replication machinery" is not a single protein or receptor, but rather a multiprotein viral enzyme complex; thus, it is not a canonical molecular target in the typical sense of a well-defined receptor or enzyme, and the term may be considered imprecise or too broad for some research databases.

Other names

HSV-1 replication machineryHSV-1 replisomeHSV-1 DNA replication complex

Inhibition of viral DNA polymerase (UL30); Inhibition of helicase–primase complex (UL5/UL8/UL52); Inhibition of viral DNA chain elongation